Fisher David insider trades
Fisher David has filed 91 Form 4s with the SEC that we hold, for Enova International, Inc. (ENVA) (Executive Chairman, Director), GoHealth, Inc. (GOCO) (Director) and FATH (Director). Across all of them we count 0 purchases worth $0 and 50 sales worth $69.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 14 sales ($38.5M). The largest single trade was a sale of 33,060 shares of Enova International, Inc. worth $6.6M, dated 2026-06-17. Of 3 sales filed since we began reading the 10b5-1 checkbox, 3 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-12 and the latest 2026-09-21.
Enova International, Inc. (ENVA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-07-09 | S, sale reported on Form 4 | 4,445 | $150.0K | 2021-07-12 | SEC |
| 2021-08-16 | S, sale reported on Form 4 | 4,736 | $150.0K | 2021-08-17 | SEC |
| 2021-09-09 | S, sale reported on Form 4 | 4,587 | $150.0K | 2021-09-13 | SEC |
| 2021-10-07 | S, sale reported on Form 4 | 20,953 | $750.1K | 2021-10-12 | SEC |
| 2021-11-15 | S, sale reported on Form 4 | 32,428 | $1.4M | 2023-12-26 | SEC |
| 2021-12-02 | S, sale reported on Form 4 | 7,977 | $300.0K | 2021-12-03 | SEC |
| 2022-01-11 | S, sale reported on Form 4 | 15,503 | $655.5K | 2022-01-13 | SEC |
| 2022-02-03 | S, sale reported on Form 4 | 7,771 | $300.0K | 2022-02-07 | SEC |
| 2022-02-04 | S, sale reported on Form 4 | 4,394 | $177.8K | 2022-02-07 | SEC |
| 2024-05-07 | S, sale reported on Form 4 | 11,876 | $743.3K | 2024-05-09 | SEC |
| 2024-05-07 | S, sale reported on Form 4 | 8,124 | $511.1K | 2024-05-09 | SEC |
| 2024-05-09 | S, sale reported on Form 4 | 10,000 | $628.8K | 2024-05-13 | SEC |
| 2024-05-14 | S, sale reported on Form 4 | 20,000 | $1.3M | 2024-05-16 | SEC |
| 2024-08-13 | S, sale reported on Form 4 | 10,000 | $798.8K | 2024-08-15 | SEC |
| 2024-08-14 | S, sale reported on Form 4 | 5,000 | $398.9K | 2024-08-15 | SEC |
| 2024-08-15 | S, sale reported on Form 4 | 10,000 | $824.9K | 2024-08-19 | SEC |
| 2024-08-19 | S, sale reported on Form 4 | 10,000 | $834.6K | 2024-08-21 | SEC |
| 2024-08-23 | S, sale reported on Form 4 | 10,000 | $844.5K | 2024-08-27 | SEC |
| 2024-11-06 | S, sale reported on Form 4 | 13,334 | $1.4M | 2024-12-05 | SEC |
| 2024-11-06 | S, sale reported on Form 4 | 13,314 | $1.4M | 2024-11-08 | SEC |
| 2024-11-26 | S, sale reported on Form 4 | 10,000 | $1.1M | 2024-11-27 | SEC |
| 2024-11-27 | S, sale reported on Form 4 | 10,000 | $1.1M | 2024-12-02 | SEC |
| 2024-12-03 | S, sale reported on Form 4 | 10,000 | $1.1M | 2024-12-05 | SEC |
| 2024-12-04 | S, sale reported on Form 4 | 10,000 | $1.1M | 2024-12-05 | SEC |
| 2025-03-25 | S, sale reported on Form 4 | 5,000 | $508.8K | 2025-03-27 | SEC |
| 2025-04-28 | S, sale reported on Form 4 | 2,000 | $197.3K | 2025-04-30 | SEC |
| 2025-05-22 | S, sale reported on Form 4 | 2,000 | $183.0K | 2025-05-27 | SEC |
| 2025-06-20 | S, sale reported on Form 4 | 2,000 | $196.8K | 2025-06-24 | SEC |
| 2025-07-14 | S, sale reported on Form 4 | 5,000 | $576.1K | 2025-07-16 | SEC |
| 2025-08-26 | S, sale reported on Form 4 | 5,000 | $589.0K | 2025-08-28 | SEC |
| 2025-08-28 | S, sale reported on Form 4 | 15,000 | $1.8M | 2025-09-02 | SEC |
| 2025-08-29 | S, sale reported on Form 4 | 10,000 | $1.2M | 2025-09-02 | SEC |
| 2025-09-04 | S, sale reported on Form 4 | 20,000 | $2.4M | 2025-09-08 | SEC |
| 2025-09-17 | S, sale reported on Form 4 | 35,000 | $4.4M | 2025-09-23 | SEC |
| 2025-09-19 | S, sale reported on Form 4 | 6,000 | $755.3K | 2025-09-23 | SEC |
| 2025-10-27 | S, sale reported on Form 4 | 6,000 | $735.7K | 2025-10-29 | SEC |
| 2025-11-21 | S, sale reported on Form 4 | 6,000 | $745.5K | 2025-11-25 | SEC |
| 2025-12-16 | S, sale reported on Form 4 | 15,000 | $2.4M | 2025-12-18 | SEC |
| 2026-01-26 | S, sale reported on Form 4 | 9,573 | $1.5M | 2026-01-28 | SEC |
| 2026-01-30 | S, sale reported on Form 4 | 37,989 | $6.3M | 2026-02-03 | SEC |
| 2026-02-18 | S, sale reported on Form 4 | 7,143 | $1.1M | 2026-02-20 | SEC |
| 2026-05-07 | S, sale reported on Form 4 | 20,000 | $3.5M | 2026-05-11 | SEC |
| 2026-05-21 | S, sale reported on Form 4 | 7,180 | $1.2M | 2026-05-26 | SEC |
| 2026-05-22 | S, sale reported on Form 4 | 3,076 | $487.4K | 2026-05-26 | SEC |
| 2026-06-17 | S, sale reported on Form 4 | 33,060 | $6.6M | 2026-06-22 | SEC |
| 2026-07-14 | S, sale reported on Form 4 | 17,006 | $3.9M | 2026-07-16 | SEC |
| 2026-07-15 | S, sale reported on Form 4 | 11,494 | $2.7M | 2026-07-16 | SEC |
| 2026-08-25 | S, sale reported on Form 4 | 9,491 | $2.3M | 2026-08-27 | SEC |
| 2026-08-26 | S, sale reported on Form 4 | 9,078 | $2.2M | 2026-08-27 | SEC |
| 2026-09-17 | S, sale reported on Form 4 | 20,750 | $3.7M | 2026-09-21 | SEC |
GoHealth, Inc. (GOCO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
FATH
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1315224) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
